GeoVax Labs (GOVX)
(Delayed Data from NSDQ)
$2.65 USD
-0.10 (-3.64%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $2.76 +0.11 (4.15%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for GeoVax Labs Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 2 | 1 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 2 | 1 |
Selling & Adminstrative & Depr. & Amort Expenses | 27 | 14 | 19 | 5 | 4 |
Income After Depreciation & Amortization | -27 | -14 | -19 | -3 | -2 |
Non-Operating Income | 1 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -26 | -14 | -19 | -3 | -2 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -26 | -14 | -19 | -3 | -2 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -26 | -14 | -19 | -3 | -2 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -27 | -14 | -19 | -3 | -2 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -27 | -14 | -19 | -3 | -2 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 1.82 | 1.13 | 0.41 | 0.09 | 0.00 |
Diluted EPS Before Non-Recurring Items | -14.29 | -12.44 | -45.58 | -32.08 | NA |
Diluted Net EPS (GAAP) | -14.29 | -12.44 | -45.58 | -32.08 | NA |
Fiscal Year end for GeoVax Labs Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 5.37 | 5.89 | 7.69 | 8.60 | 6.18 |
Income After SG&A, R&D, and Dept/Amort Expenses | -5.07 | -5.89 | -7.69 | -8.60 | -6.18 |
Non-Operating Income | 0.01 | 0.03 | 0.10 | 0.19 | 0.25 |
Interest Expense | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -5.06 | -5.85 | -7.59 | -8.41 | -5.93 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -5.06 | -5.85 | -7.59 | -8.41 | -5.93 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -5.06 | -5.85 | -7.59 | -8.41 | -5.93 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 2.55 | 2.37 | NA | 1.75 | 1.80 |
Diluted EPS Before Non-Recurring Items | -1.99 | -2.47 | NA | -4.80 | -3.30 |
Diluted Net EPS (GAAP) | -1.99 | -2.47 | -3.95 | -4.80 | -3.30 |